Brille Brian J 4

What Happened

• Brian J. Brille, Vice Chairman and Executive Vice President of Caris Life Sciences (also listed as a director), had 13,987 restricted stock units (RSUs) withheld to satisfy tax withholding obligations on May 15, 2026. The shares were valued at $15.25 each, totaling $213,302. The transaction is reported as a disposal via tax withholding (transaction code F), not an open-market sale.

Key Details

• Transaction date and price: 2026-05-15; 13,987 shares withheld at $15.25/share.
• Transaction value: Approximately $213,302.
• Filing date: 2026-05-18 — filed within the SEC Form 4 reporting window (timely).
• Footnotes: F1 indicates shares were withheld to pay taxes on the vesting/settlement of RSUs. F2 notes the reporting person disclaims beneficial ownership except to the extent of pecuniary interest. F3 notes shares are held via a consolidated family trust.
• Shares owned after transaction: Not specified in the filing.

Context

• This was a routine tax-withholding transaction related to RSU vesting (cashless share withholding), not a discretionary selling decision on the open market. Such withholdings are common and generally do not signal insider sentiment about the company’s stock.